Skip to main content
. 2018 Feb 26;41(3):378–384. doi: 10.1002/clc.22880

Table 2.

Clinical characteristics at the time of hospital admission according to presence or absence of elevated Lp(a) and FH phenotype

Variable Lp(a) ≥0.5 g/L Lp(a) <0.5 g/L p Value FH+ FH– p Value
Age, y 58.7 ± 12.5 61.8 ± 13.9 0.075 56.4 ± 10.6 61.6 ± 13.9 0.028
Male sex 59.0 73.8 0.012 61.1 71.0 0.225
HTN 49.4 52.8 0.595 55.6 51.3 0.627
T2DM 28.9 30.9 0.736 44.4 28.3 0.047
Ever smoked 36.1 40.8 0.459 41.7 39.4 0.796
Statin at admission 42.7 36.8 0.346 80.6 32.6 <0.001
Cr, μmol/L, median (IQR) 76.6 (72.3–81.0) 81.7 (78.0–85.5) 0.128 85.1 (75.5–95.9) 79.7 (76.6–82.9) 0.266
TC, mmol/L 5.1 ± 1.4 4.8 ± 1.4 0.044 5.9 ± 1.4 4.7 ± 1.2 <0.001
HDL‐C, mmol/L 1.1 ± 0.3 1.0 ± 0.3 0.067 1.0 ± 0.2 1.1 ± 0.3 0.733
TG, mmol/L, median (IQR) 1.5 (1.4–1.7) 1.6 (1.5–1.7) 0.605 2.0 (1.6–2.4) 1.5 (1.4–1.6) 0.015
LDL‐C, mmol/L 3.2 ± 1.2 2.9 ± 1.1 0.011 3.9 ± 1.2 2.9 ± 1.0 <0.001
Adjusted LDL‐C, mmol/La 3.7 ± 2.3 3.5 ± 1.2 0.149 6.7 ± 2.0 3.1 ± 0.92 <0.001
Non–HDL‐C, mmol/L 4.0 ± 1.4 3.7 ± 1.3 0.099 4.8 ± 1.4 3.6 ± 1.2 <0.001
LDL‐C, mmol/L
>1.8 90.4 80.2 0.035 100 80.6 0.004
>2.5 30.1 36.6 0.285 91.7 61.6 <0.001
Lp(a), g/Lb 0.85 (0.79‐0.92) 0.13 (0.12‐0.14) <0.001 0.28 (0.19‐0.41) 0.20 (0.18‐0.22) 0.062

Abbreviations: CI, confidence interval; Cr, creatinine; FH, familial hypercholesterolemia; HDL‐C, high‐density lipoprotein cholesterol; HTN, hypertension; IQR, interquartile range; LDL‐C, low‐density lipoprotein cholesterol; Lp(a), lipoprotein(a); SD, standard deviation; T2DM, type 2 diabetes mellitus; TC, total cholesterol; TG, triglycerides.

Data are presented as percentages or mean ± SD, unless otherwise noted.

a

LDL‐C adjusted for statin therapy and the cholesterol content of Lp(a).

b

Data presented as the geometric mean and 95% CI.